Our privacy policy describes how Fidessa uses cookies on our website. If you continue using our website, you are consenting to our use of cookies. OK

Turquoise breaks into double figures

Last Friday, Turquoise achieved over 10% market share in four FTSE 100 stocks – Wolsey, Tesco, Drax and Kingfisher. Interestingly, Chi-X had a good slice of these stocks too and so it looks like the first hard evidence is emerging that some FTSE 100 stocks will fragment substantially over multiple MTFs. Most significant was that nearly 40% of Kingfisher (FFI 2.17) was traded away from the primary exchange on alternative MTFs. This is good news for new venues like BATS and Nasdaq OMX as it seems to indicate that there is no defined limit yet as to how far a stock will fragment away from its primary market. Some observers thought that the new MTFs would be scrabbling over the same amount of “alternative” liquidity. In fact, it seems that the opposite is the case and that, as more alternative venues launch, then more and more liquidity will divert to the new venues.

The bigger question, though, concerns viability. Just because an alternative venue can attract market share in some stocks there’s no guarantee that it can actually make money. I saw today that Nasdaq is extending its net zero pricing model in “its determination to attract liquidity”. Whilst this is to be applauded, I continue to think that new venues need to understand why some stocks fragment more than others and focus on these. History shows that there are no winners in wars of attrition. In my view it is far better to find a niche and expand outwards than it is to attack on all fronts.

Leave a comment

Copyright © 2019 Fidessa Group Holdings Limited. All rights reserved.

The information contained within this website is provided for informational purposes only. Fidessa will use reasonable care to ensure that information is accurate at the time it is made available, and for the duration that it remains on the site. The information may be changed by Fidessa at any time without notice. We also reserve the right to close the website at any time. No representation or warranty, expressed or implied, is given on behalf of Fidessa or any of its respective directors, employees, agents, or advisers as to the accuracy or completeness of the information or opinions contained herein or its suitability for any purpose and, save in the case of fraud, all liability for direct, indirect, special, consequential or other loss or damages of whatever kind that may arise from use of the website is hereby excluded to the fullest extent permitted by law. Any decisions you make based on the information in this website are your sole responsibility and information on the website should not be relied upon in connection with any investment decision.

The copyright of this website belongs to Fidessa. All other intellectual property rights are reserved.

Fragulator® is a registered trademark of Fidessa Group Holdings Limited.

Reproduction or redistribution of this information is prohibited except with written permission from Fidessa.